Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Med Manor Organics develops and markets a broad portfolio of generic and branded pharmaceuticals across multiple therapeutic areas, with leading positions in dermatology, pediatrics, trichology, gynecology, neuro-psychiatry, and cardio-diabetic segments. It operates state-of-the-art WHO-GMP compliant manufacturing facilities and has launched over 40 SKU products, including innovative brands in both allopathic and Ayurvedic segments. Its portfolio includes various combinations of antibiotics, antiemetics, antiseptics, nutritional supplements, and personal care products. In oncology, the company is engaged in R&D collaborations targeting affordable cancer therapies for developing nations.[1][3][5][6][7][10]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Med Manor Organics.